P145 Membranous and proliferative lupus nephritis – analysis of a nationwide multicentre cohort
Filipa Farinha(Instituto Politécnico de Santarém), María José Santos(University of Lisbon), Anisur Rahman(University College London), Diogo Fonsêca(Centro Hospitalar de Vila Nova de Gaia), Joana Rodrigues(Administração Regional de Saúde de Lisboa e Vale do Tejo), Mariana Luís(University of Coimbra), Rita Pinheiro Torres(Hospital de Egas Moniz), Raquel Freitas(Hospital Garcia de Orta), Margarida Cunha(Hospital Garcia de Orta), Maura Couto(Centro Hospitalar Tondela-Viseu), Bernardo Santos(Centro Hospitalar do Baixo Vouga), Carla Macieira(Centro Hospitalar Lisboa Norte), Luís Inês(University of Beira Interior), Ruth J. Pepper(University College Hospital), Sofia Barreira(Centro Hospitalar Lisboa Norte)
Cited by 0
Related Papers
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
|Annals of the Rheumatic Diseases|2014|726
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids
|Annals of the Rheumatic Diseases|2013|454
A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)
|Annals of the Rheumatic Diseases|2016|355
2021 DORIS definition of remission in SLE: final recommendations from an international task force
|Lupus Science & Medicine|2021|340